Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal microbiota restoration after bacterial vaginosis treatment
ChiCTR-TRC-11001484Phase 4Completed
- Sponsor
- Zhejiang University
- Start
- Nov 2010
- Modality
- Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of metronidazole and lactobacillus delbrueckii DM8909 in bacterial vaginosis (BV) (4 arms), sponsored by Zhejiang University. Primary endpoint: Vaginal bacterial diversity. Started Nov 2010; status: completed.
02
Drugs
metronidazolelactobacillus delbrueckii DM8909
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR-TRC-11001484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001484.